APA (7th ed.) Citation

HK, L., TS, W., Y, R., YC, K., CY, L., PJ, L., . . . SW, T. (2025). Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors. Journal for immunotherapy of cancer, 13(7), . https://doi.org/10.1136/jitc-2024-010500

Chicago Style (17th ed.) Citation

HK, Li, et al. "Allogeneic Cetuximab-armed Gamma Delta T Cells Using Antibody-cell Conjugation Technology for the Treatment of EGFR-expressing Solid Tumors." Journal for Immunotherapy of Cancer 13, no. 7 (2025). https://doi.org/10.1136/jitc-2024-010500.

MLA (9th ed.) Citation

HK, Li, et al. "Allogeneic Cetuximab-armed Gamma Delta T Cells Using Antibody-cell Conjugation Technology for the Treatment of EGFR-expressing Solid Tumors." Journal for Immunotherapy of Cancer, vol. 13, no. 7, 2025, https://doi.org/10.1136/jitc-2024-010500.